NCT03315611View on ClinicalTrials.gov

"Study to Assess the Effect of Eucerin AtopiControl on Dermal Symptoms in Patients With Atopic Dermatitis"

NACompletedINTERVENTIONAL
Enrollment

23

Participants

Timeline

Start Date

October 2, 2017

Primary Completion Date

April 25, 2018

Study Completion Date

April 25, 2018

Conditions
Atopic DermatitisAllergy Pollen
Interventions
DRUG

'Eucerin AtopiControl Lotion' (for the body)

Treatment with Eucerin AtopiControl Lotion

OTHER

Allergen challenge chamber

Exposure to Dactylis glomerata pollen in an environmental challenge chamber

Trial Locations (1)

30625

Fraunhofer ITEM, Hanover

All Listed Sponsors
collaborator

Hannover Medical School

OTHER

lead

Fraunhofer-Institute of Toxicology and Experimental Medicine

OTHER

NCT03315611 - "Study to Assess the Effect of Eucerin AtopiControl on Dermal Symptoms in Patients With Atopic Dermatitis" | Biotech Hunter | Biotech Hunter